Previous 10 | Next 10 |
Gainers: Emmaus Life Sciences ( OTC:EMMA ) +64% . PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +23% . SYNNEX Corporation (NYSE: SNX ) +20% . Contango Oil & Gas Company (NYSEMKT: MCF ) +17% . R.R. Donnelley & Sons Company (NYSE: RRD ) +16% . Comtech Telecommunications (NASDAQ...
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced the schedule of two oral presentations and five posters that will be presented at the 2019 Annual Meeting of the North American Menopause Society (NAMS) being held on September 25-28, 2019, r...
Gainers: AXU +5.7% . EPM +3.5% . NKTR +3.4% . MRNA +3.3%. TXMD +2.4% . More news on: Alexco Resource Corp., Evolution Petroleum Corporation, Nektar Therapeutics, Stocks on the move, , News on ETFs Read more ...
Shares of TherapeuticsMD (NASDAQ: TXMD) jumped 34% in August, according to data provided by S&P Global Market Intelligence , after the drugmaker reported solid second-quarter earnings and increased its guidance for the year. Part of the August jump had to do with the disappointing ...
Repression may begin as a means to an end, but it always ends up being an end unto itself ” - Garry Kasparov After the biggest one-day loss (over 800 points on the Dow) for the market in 2019 last Wednesday, stocks have recovered most of their losses after a slight rebound on Thu...
We closely follow high Short interest stocks because the group often times presents good trading opportunities and contrarian investment ideas with potentially significant mispricing opportunities. There are many ways to analyze Short interest data, in some ways it's a backwards looking indi...
TherapeuticsMD ( TXMD ) just reported a mixed Q2 earnings with a $0.06 miss on EPS and a $0.96M beat on revenue. TXMD reported net revenue of $6.08M, which was a 61.7% increase year-over-year and was above the company's guidance of $4.5-5.5M. IMVEXXY's net revenue was up 55% compared to ...
TherapeuticsMD ( TXMD ) had a stellar run after earnings, up a massive 65% in 3 days. In the following, I like to evaluate how my call did and discuss what is actually driving the share price higher. How did my call play out? To recap , I predicted an earnings beat, potential hike in guid...
August 12, 2019 Palm Beach, FL – August 12, 2019 – Cellulite has been the bane of many women (and men too) for years, but the market is expected to rise significantly through 2026, industry reports project. One report said that the global cellulite treatment market...
Arcadia Biosciences (NASDAQ: RKDA ) +62% on USDA OK of drought-tolerant soybean strain. More news on: Arcadia Biosciences, Inc., Puma Biotechnology, Inc., Callaway Golf Company, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...